Valvular heart disease cardiac catheterization: Difference between revisions
Jump to navigation
Jump to search
(/* 2006 ACC/AHA Guidelines for the Management of Patients with Valvular Heart Disease - Indications for Cardiac Catheterization in Aortic Stenosis Patients (DO NOT EDIT) {{cite journal |author=Bonow RO, Carabello BA, Kanu C, et al. |title=ACC/AHA ...) |
Ochuko Ajari (talk | contribs) No edit summary |
||
Line 26: | Line 26: | ||
==References== | ==References== | ||
{{ | {{Reflist|2}} | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Valvular heart disease]] | |||
[[Category:Primary care]] | |||
{{WH}} | |||
{{WS}} |
Revision as of 14:52, 22 April 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Valvular heart disease Microchapters |
2006 ACC/AHA Guidelines for the Management of Patients with Valvular Heart Disease - Indications for Cardiac Catheterization in Aortic Stenosis Patients (DO NOT EDIT) [1]
Class I |
"1. Coronary angiography is recommended before Aortic valve replacement in patients with aortic stenosis at risk for Coronary heart disease. (Level of Evidence: B) " |
"2. Cardiac catheterization for hemodynamic measurements is recommended for assessment of severity of AS in symptomatic patients when noninvasive tests are inconclusive or when there is a discrepancy between noninvasive tests and clinical findings regarding severity of AS. (Level of Evidence: C)" |
"3. Coronary angiography is recommended before AVR in patients with Aortic stenosis for whom a pulmonary autograft (Ross procedure) is contemplated and if the origin of the coronary arteries was not identified by noninvasive technique. (Level of Evidence: C)" |
Class III (Harm) |
"1. Cardiac catheterization for hemodynamic measurements is not recommended for the assessment of severity of AS before AVR when noninvasive tests are adequate and concordant with clinical findings. (Level of Evidence: C) " |
"2. Cardiac catheterization for hemodynamic measurements is not recommended for the assessment of LV function and severity of AS in asymptomatic patients. (Level of Evidence: C) " |
References
- ↑ Bonow RO, Carabello BA, Kanu C; et al. (2006). "ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons". Circulation. 114 (5): e84–231. doi:10.1161/CIRCULATIONAHA.106.176857. PMID 16880336. Unknown parameter
|month=
ignored (help)